178 related articles for article (PubMed ID: 11880357)
1. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development.
Roberts LM; Visser JA; Ingraham HA
Development; 2002 Mar; 129(6):1487-96. PubMed ID: 11880357
[TBL] [Abstract][Full Text] [Related]
2. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
3. The in vivo roles of müllerian-inhibiting substance.
Behringer RR
Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
[TBL] [Abstract][Full Text] [Related]
4. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of hormone-mediated Müllerian duct regression: involvement of beta-catenin.
Allard S; Adin P; Gouédard L; di Clemente N; Josso N; Orgebin-Crist MC; Picard JY; Xavier F
Development; 2000 Aug; 127(15):3349-60. PubMed ID: 10887090
[TBL] [Abstract][Full Text] [Related]
6. The müllerian inhibitor and mammalian sexual development.
Behringer RR
Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
[TBL] [Abstract][Full Text] [Related]
7. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
[TBL] [Abstract][Full Text] [Related]
8. Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.
Park JH; Tanaka Y; Arango NA; Zhang L; Benedict LA; Roh MI; Donahoe PK; Teixeira JM
Dev Biol; 2014 Feb; 386(1):227-36. PubMed ID: 24362065
[TBL] [Abstract][Full Text] [Related]
9. Genetic studies of MIS signalling in sexual development.
Jamin SP; Arango NA; Mishina Y; Behringer RR
Novartis Found Symp; 2002; 244():157-64; discussion 164-8, 203-6, 253-7. PubMed ID: 11990789
[TBL] [Abstract][Full Text] [Related]
10. New insights into mullerian inhibiting substance and its mechanism of action.
Lane AH; Donahoe PK
J Endocrinol; 1998 Jul; 158(1):1-6. PubMed ID: 9713320
[TBL] [Abstract][Full Text] [Related]
11. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
12. Paracrine-mediated apoptosis in reproductive tract development.
Roberts LM; Hirokawa Y; Nachtigal MW; Ingraham HA
Dev Biol; 1999 Apr; 208(1):110-22. PubMed ID: 10075845
[TBL] [Abstract][Full Text] [Related]
13. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
[TBL] [Abstract][Full Text] [Related]
14. AMH signaling: from receptor to target gene.
Visser JA
Mol Cell Endocrinol; 2003 Dec; 211(1-2):65-73. PubMed ID: 14656478
[TBL] [Abstract][Full Text] [Related]
15. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.
Behringer RR; Cate RL; Froelick GJ; Palmiter RD; Brinster RL
Nature; 1990 May; 345(6271):167-70. PubMed ID: 2336108
[TBL] [Abstract][Full Text] [Related]
16. Mullerian inhibiting substance: a gonadal hormone with multiple functions.
Lee MM; Donahoe PK
Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone, beta-catenin and Müllerian duct regression.
Xavier F; Allard S
Mol Cell Endocrinol; 2003 Dec; 211(1-2):115-21. PubMed ID: 14656484
[TBL] [Abstract][Full Text] [Related]
18. Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade.
Shen WH; Moore CC; Ikeda Y; Parker KL; Ingraham HA
Cell; 1994 Jun; 77(5):651-61. PubMed ID: 8205615
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
Kurian MS; de la Cuesta RS; Waneck GL; MacLaughlin DT; Manganaro TF; Donahoe PK
Clin Cancer Res; 1995 Mar; 1(3):343-9. PubMed ID: 9815990
[TBL] [Abstract][Full Text] [Related]
20. Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.
Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
Mol Cell Endocrinol; 2003 Dec; 211(1-2):15-9. PubMed ID: 14656471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
